Suebwong Chuthapisith

Summary

Affiliation: University of Nottingham
Country: UK

Publications

  1. ncbi Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
    Sukchai Satthaporn
    Section of Surgery, Queen s Medical Centre, Nottingham University Hospitals, Nottingham, UK
    BMC Immunol 9:32. 2008
  2. ncbi Neoadjuvant chemotherapy in women with large and locally advanced breast cancer: chemoresistance and prediction of response to drug therapy
    S Chuthapisith
    Department of Surgery, Queen s Medical Centre, University of Nottingham, Nottingham, UK
    Surgeon 4:211-9. 2006
  3. ncbi Principles of proteomics and its applications in cancer
    S Chuthapisith
    Department of Surgery, Queen s Medical Centre, University of Nottingham, Nottingham, NG7 2UH, England, UK
    Surgeon 5:14-22. 2007
  4. ncbi Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs
    Suebwong Chuthapisith
    Department of Surgery, Queen s Medical Centre, Nottingham NG7 2UH, UK
    Int J Oncol 30:1545-51. 2007
  5. ncbi 18F-FDG dual-headed gamma camera PET in detection of axillary nodal disease in patients with large or locally advanced breast cancer: possible alternative staging of axilla
    Syed Mustafa
    Medical Physics, Lincoln County Hospital, Lincoln, UK
    Oncol Rep 18:1545-9. 2007
  6. ncbi Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review)
    Suebwong Chuthapisith
    Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    Oncol Rep 20:699-703. 2008

Collaborators

  • I D Kerr
  • Robert Layfield
  • Christopher Marshall
  • Sukchai Satthaporn
  • Jibril A Jibril
  • Oleg Eremin
  • Syed Mustafa
  • Richard A Robins
  • David Valerio
  • Wichai Vassanasiri
  • David Clark
  • Mohamad El-Sheemy
  • Chandan Verma
  • Alasdair J McKechnie
  • Mark M Aloysius
  • Mohammed El Sheemy
  • Mohammed El-Sheemy
  • Peter A Griffiths
  • Jennifer M Eremin
  • David C Wheatley

Detail Information

Publications6

  1. ncbi Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
    Sukchai Satthaporn
    Section of Surgery, Queen s Medical Centre, Nottingham University Hospitals, Nottingham, UK
    BMC Immunol 9:32. 2008
    ..Reversal of this dysfunction and establishment of optimal DC function is a key prerequisite for the induction of effective anti-cancer immune responses...
  2. ncbi Neoadjuvant chemotherapy in women with large and locally advanced breast cancer: chemoresistance and prediction of response to drug therapy
    S Chuthapisith
    Department of Surgery, Queen s Medical Centre, University of Nottingham, Nottingham, UK
    Surgeon 4:211-9. 2006
    ..However, no single biomarker appears to be effective. Genomics is a novel biotechnological process which is being used to predict response to drug therapy; this work is currently at an early stage of development..
  3. ncbi Principles of proteomics and its applications in cancer
    S Chuthapisith
    Department of Surgery, Queen s Medical Centre, University of Nottingham, Nottingham, NG7 2UH, England, UK
    Surgeon 5:14-22. 2007
    ..These technologies, particularly when combined with genomic analyses, will provide valuable insights into the molecular basis of carcinogenesis and the development of more effective anti-cancer therapies...
  4. ncbi Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs
    Suebwong Chuthapisith
    Department of Surgery, Queen s Medical Centre, Nottingham NG7 2UH, UK
    Int J Oncol 30:1545-51. 2007
    ....
  5. ncbi 18F-FDG dual-headed gamma camera PET in detection of axillary nodal disease in patients with large or locally advanced breast cancer: possible alternative staging of axilla
    Syed Mustafa
    Medical Physics, Lincoln County Hospital, Lincoln, UK
    Oncol Rep 18:1545-9. 2007
    ..In conclusion, GCPET is a reliable method and can be performed in a district general hospital and detecting disease in axillary nodes in certain patients, possibly obviating the need for surgery...
  6. ncbi Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review)
    Suebwong Chuthapisith
    Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    Oncol Rep 20:699-703. 2008
    ..We describe and discuss these molecular characteristics and approaches and their applications to NAC in breast cancer management...